Recent developments in beta-blockers and anaesthesia

Current Opinion in Anaesthesiology
Andreas Meissner

Abstract

To evaluate developments on the subject of beta-blockers and anaesthesia published in the past 12 months. The administration of beta-blockers has been established as a pharmacological approach to reduce cardiac events in the perioperative period. A number of studies and reviews have been published underlining the appropriateness of this approach in patients undergoing non-cardiac as well as cardiac surgery. A lack of transfer of the scientific knowledge to clinical practice is evident not only in the field of perioperative medicine, which results in an under-use of beta-blockers. Open questions are still directed towards the optimal dosage, the effectiveness of chronic beta-blockade and the effects of beta-blockade in traumatized and burned patients. Progress in the use of beta-blockers has been realized by the introduction of institutional protocols. In chronic beta-blockade a simple continuation does not provide effective protection. Improved protection might be gained by the combination of beta-blockers and statins in high-risk patients. The role of beta-blockers in pain management is currently a field of interest, although there seem to be many open questions. There are still doubts about the evidence of perioperative beta-...Continue Reading

References

Feb 1, 1997·Journal of Cardiothoracic and Vascular Anesthesia·S YndgaardP G Berthelsen
Nov 7, 1999·Anesthesiology·F ClergueM C Laxenaire
Apr 20, 2001·JAMA : the Journal of the American Medical Association·E BoersmaUNKNOWN DECREASE Study Group (Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiogrpahy)
Oct 30, 2001·The New England Journal of Medicine·D N HerndonR R Wolfe
Dec 19, 2002·British Journal of Anaesthesia·P W C ten BroeckeH F Adriaensen
Feb 1, 2003·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Samuel ArmaniousFrances Chung
Jun 28, 2003·The American Journal of Medicine·Duminda N WijeysunderaW Scott Beattie
Jul 24, 2003·Journal of the American College of Cardiology·Stephanie H WilsonPeter B Berger
Aug 29, 2003·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Michael ZauggEliana Lucchinetti
Jan 24, 2004·Cardiac Electrophysiology Review·Jeffrey W H FungJohn E Sanderson
Feb 20, 2004·Journal of Cardiothoracic and Vascular Anesthesia·Lee A FleisherDon Poldermans
Mar 6, 2004·The Journal of Thoracic and Cardiovascular Surgery·Duminda N WijeysunderaKeyvan Karkouti
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Joseph P MathewUNKNOWN Multicenter Study of Perioperative Ischemia Research Group
Apr 24, 2004·Anesthesia and Analgesia·John V BoothUNKNOWN Duke Heart Center Perioperative Desensitization Group
Aug 4, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·P J DevereauxGordon H Guyatt
Sep 4, 2004·Annales Françaises D'anesthèsie Et De Rèanimation·T GeeraertsJ Marty
Sep 8, 2004·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·M D KertaiD Poldermans
Oct 8, 2004·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·P J DevereauxHomer Yang
Nov 9, 2004·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·J A S BrookesC C R Bishop
Nov 16, 2004·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Yavuz EncSertac Cicek

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.